UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory scrutiny. Experts point to its aggressive Medicare Advantage strategy and a rapidly evolving healthcare landscape as key drivers of its challenges.
Address real-world critical care issues and improve patient care at the Society of Critical Care Medicine's Datathon. Attend July 19-20 near Chicago to collaborate and revolutionize healthcare with some of the most talented and innovative clinical and data professionals. Sponsorship opportunities are available. Register now.
About six months after rolling out voice AI in its call centers, Allina Health is already seeing signs that the tool is doing a good job of improving the patient experience. The technology is reducing patients' average call times by 5-10 seconds, and 80% of calls are now answered in 45 seconds or less.
Merck KGaA's pimicotinib led to statistically significant improvement on multiple measures of its Phase 3 test in tenosynovial giant cell tumor, positioning the drug to potentially compete with medications from Daiichi Sankyo and Ono Pharma. The Phase 3 results were presented during the annual meeting of the American Society of Clinical Oncology.
What if the kind of cuts we should be talking about are the ones that actually make care better? Like cutting confusion. Because for many people, the biggest barrier to healthcare access isn't cost or availability – it's complexity.
At MedCity INVEST, Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, discussed the strategies he's seeing employers implement around GLP-1s.
He noted that many employers are taking a "middle ground" approach—such as covering the drugs for individuals with higher BMIs—and are also providing lifestyle support.
Radiologists today face a surge in imaging volume and pressure to produce fast, accurate reports. Workflow optimization is about delivering the right results at the right time with less friction.
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
No comments